Corporate / M&A

Regulatory

Homburger News

20250320_UBS

Homburger advised UBS on the merger of pension foundations

In December 2024, UBS took another step in the integration of Credit Suisse and closed the mergers of the vested benefits foundations (Pillar 2 &#8211; FZG) of UBS and Credit Suisse as well as of the Pillar 3a foundations of UBS and Credit Suisse. These mergers ensure that all beneficiaries of the foundations have equal access to the service offerings of UBS.
The Homburger team advising on the mergers comprised Andreas Müller, Francesco Bernasconi and Thierry Burckhardt (all Corporate / M&amp;A) and Peter Müller (Tax / Pensions).

Homburger advised UBS on the merger of pension foundations 

Financing and Investment Products

Real Estate

Homburger for HR Group

20250310_HR Group

The Berlin-based HR Group has acquired H-Hotels, one of the largest privately managed German hotel companies. The transaction took effect on February 25, 2025, and comprises more than 60 hotels in Germany, Austria, Switzerland, France and Hungary.  Homburger acts as Swiss transaction counsel to HR Group.

Homburger advised HR Group on its acquisition of H-Hotels

The Berlin-based HR Group has acquired H-Hotels, one of the largest privately managed German hotel companies. The transaction took effect on February 25, 2025, and comprises more than 60 hotels in Germany, Austria, Switzerland, France and Hungary.
Homburger acts as Swiss transaction counsel to HR Group.
Homburger acted as Swiss transaction counsel to HR Group. The Homburger team comprised Andreas Müller, Anna Peter, Thierry Burckhardt, Miriam Oelgarth and Carolina Rodriguez (all Corporate / M&amp;A), Stefan Bindschedler and Michelle Wolf (both Financing and Investment Products), Stefan Gäumann and Olivier Bühlmann (both Real Estate) as well as Stefan Oesterhelt and Philippe Gobet (Tax).

IP / IT

Capital Markets

Employment and Executive Compensation

Bioversys

20250129_Bioversys

On January 29, 2025, BioVersys AG, a clinical-stage biopharmaceutical company developing and commercializing novel antibacterial products for life-threatening infections domiciled in Basel, Switzerland, announced the launch of its Initial Public Offering (IPO) on SIX Swiss Exchange, the publication of the offer price and the start of the bookbuilding process. The IPO comprises a primary offering targeting gross proceeds of CHF 80 m (including an over-allotment option targeting gross proceeds of CHF 5 m). The implied market capitalization of the company, assuming all offered shares are sold in the IPO and the over-allotment option is exercised in full, is approximately CHF 212.9 m. The first day of trading is expected to be February 7, 2025.
BioVersys focuses on identifying, developing and commercializing novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The Company&#8217;s most advanced R&amp;D programs address nosocomial pneumonia and blood stream infections caused by Acinetobacter baumannii (BV100, phase 3-ready) and tuberculosis (alpibectir, phase 2a). In addition to its domicile in the biotech hub in Basel, Switzerland, BioVersys has operations in in Lille, France, Delaware, United States and Guangzhou, China.
Citigroup Global Markets Limited, UBS AG and Stifel Europe AG are acting as Joint Global Coordinators and Joint Bookrunners on the IPO, Mirabaud &amp; Cie SA and Octavian AG as Selling Agents.
Homburger is advising BioVersys on all aspects of the IPO as lead counsel. The Homburger team is co-led by Dieter Gericke and Lorenzo Togni and includes Thierry Burckhardt, Magda Aref, Simone Schmid, Raphael Linder, Harun Cetin and Leander Etter (all Corporate / M&amp;A and Capital Markets). Luca Dal Molin and Kristina Martinovic (both IP / IT) are providing intellectual property advice, Jeremy Reichlin (Employment and Executive Compensation) is providing employment and executive compensation advice, and Reto Heuberger and Philippe Weber (both Tax) are providing tax advice.

Thierry
Burckhardt

Homburger advised UBS on the merger of pension foundations

Homburger advised HR Group on its acquisition of H-Hotels

Homburger advises BioVersys AG on its IPO on SIX Swiss Exchange

Private Equity 2025: Switzerland

Private Equity 2024: Switzerland

Join the Team

Thierry Burckhardt

Career

Languages

Bar Registration

Teams

ThierryBurckhardt

Homburger advised UBS on the merger of pension foundations

Homburger advised HR Group on its acquisition of H-Hotels

Homburger advises BioVersys AG on its IPO on SIX Swiss Exchange

Private Equity 2025: Switzerland

Private Equity 2024: Switzerland

Join the Team

Thierry Burckhardt

Career

Languages

Bar Registration

Teams

Thierry
Burckhardt